CHICAGO, May 14, 2024
/PRNewswire/ -- According to Arizton's latest research report,
the global blood culture tests market is growing at a CAGR of
7.81% during the forecast period.
To Know More, Click:
https://www.arizton.com/market-reports/blood-culture-tests-market
Browse In-depth TOC on the Blood Culture Tests
Market
314 – Pages
123 - Tables
132 - Figures
Blood Culture Tests Market Report Scope
Report
Attributes
|
Details
|
Market Size
(2029)
|
USD 8.98
Billion
|
Market Size
(203)
|
USD 5.72
Billion
|
CAGR
(2023-2029)
|
7.81 %
|
Historic
Year
|
2020-2022
|
Base
Year
|
2023
|
Forecast
Year
|
2024-2029
|
Geographic
Analysis
|
North America, Europe,
APAC, Latin America, and Middle East & Africa
|
Market
Dynamics
|
- Increasing
Prevalence of Sepsis
- Rising Burden of
Bloodstream Infections
- Growing Demand for
Early & Preventive Diagnosis
|
The growing burden of infectious diseases associated with the
bloodstream is a major factor fueling the demand for blood culture
tests. The increasing demand for blood culture testing, which
results in growing research across the sector, delivers new
pathways to improve blood culture tests through increasing the
test's efficacy, turnaround time, and specificity. Sepsis is a
rapidly growing global health concern, boosting the demand for
early and preventive diagnosis. Sepsis poses a substantial economic
burden, and government support for preventive measures is
increasing. Blood culture is considered the gold standard
in BSI disease diagnosis worldwide. Worldwide, the growing
awareness of sepsis management positively influences the demand for
blood culture tests.
Vendors Analysis
- Danaher is one of the major companies operating in the blood
culture test market. After the acquisition of Cepheid in 2016, the
company expanded its presence in the market and witnessed increased
market penetration of its products. It offers blood culture systems
and tests. The company continuously focuses on blood culture test
systems by integrating advanced tools. The increasing focus on the
diagnostic sector and associated global programs are key
considerations of the companies to increase consumer base and
revenue growth opportunities for blood culture test solutions.
- Terumo Corporation contributes to the global blood culture
tests market by offering blood culture test equipment and
consumables. The company provides solutions for processing donated
blood and products and collecting blood components for several
procedures, including blood culture tests. It has a strong consumer
base across blood centers, medical institutes, research institutes,
and pharma companies. The company increased its focus on digital
solutions for blood and cell technology products.
- Bruker is one of the leading companies working toward the
requirement of accurate and rapid solutions to achieve rapid
detection and resistance detection from positive blood culture
solutions. Its MALDI Biotyper has revolutionized microbial
identification, offering reliable, fast, easy, robust, and
cost-effective solutions. The company has focused efforts on
developing a novel solution using MALDI Biotyper to reduce
microbial detection and phenotypic resistance detection within 60
to 90 minutes after a positive blood culture alert.
Development in Automated Blood Culture Test
Globally, the first automated blood culture test system that was
created and used in the early 1970s was the BACTEC 460 Radiometric
Blood Culture Test, followed by the BACTEC 660, a 730
non-radiometric blood culture test. These systems were developed
based on the advanced and best technologies available at the time.
After that, the BACTEC 460 system was later successfully developed
and adopted for use with mycobacterial cultures till the 1990s. In
the 1980s, the development of sensor technology allowed for the
development of bottles that allow for non-invasive monitoring for
markers of microbe growth and monitoring to enable earlier
detection. Previous automated blood culture tests relied on
predefined numeric threshold values to show sufficient CO2 creation
in bottles to be identified as positive with a resulting subculture
and Gram stain.
In the past few years, the development of blood culture systems
and newer molecular methods for identifying bloodstream infection
in blood culture has evolved along with and been accelerated by
advances in knowledge of the critical factors in recovering
microbial pathogens from blood, changes in the epidemiology of
bloodstream pathogens and changes in technology, changes in
expectation associating the prompter availability of blood culture
results.
Regional Overview
North America emerges as the
dominant force in the global blood culture tests market, capturing
a substantial 35% share of the revenue in 2023. The region's
prominence is fueled by the escalating incidence of bloodstream
infections in hospital environments, the growing challenge of
managing sepsis, and the rising recognition and adoption of
automated blood culture systems. Furthermore, the concentration of
key market players in the U.S. amplifies demand and uptake of blood
culture testing equipment and consumables, propelling market
expansion.
Meanwhile, the Asia-Pacific
(APAC) region is poised to experience the highest compound annual
growth rate (CAGR) in the global blood culture tests market
throughout the forecast period. This growth trajectory in APAC is
underpinned by the mounting burden of infectious diseases,
including bloodstream infections, sepsis, and hospital-acquired
infections. The rapid advancements in healthcare and life sciences
further drive market proliferation. Countries like China and India stand out as leaders in diagnostic
developments for preventive measures and early disease detection,
promising significant market growth within these expanding
markets.
The Blood Culture Tests Market Report
Encompasses Crucial Data, Including:
CAGR (Compound Annual Growth Rate) during the forecast
period: This metric provides insights into the annual
growth rate of the blood culture tests market over the
specified time frame.
Detailed information on growth drivers: The report
offers in-depth information on the factors that will propel the
blood culture tests market growth from 2023 to 2029. This
includes an analysis of various market
influences.
Precise estimation of market size: Accurate assessments
of the blood culture tests market size and its contribution
and focusing on key market segments.
Predictions about upcoming trends and changes in consumer
behavior: The report offers insights into anticipated
trends and shifts in consumer behavior that are likely to impact
the blood culture tests market, helping businesses prepare for
future market dynamics.
Geographical market growth: The report covers the
development of the blood culture tests market across different
regions, including North America,
Europe, APAC, Latin America, the Middle East, and Africa. This provides a comprehensive
understanding of the market's global
landscape.
Competitive landscape analysis: A thorough examination
of the market's competitive landscape is presented, including
detailed information about companies operating in the blood culture
tests market. This includes an overview of key players, their
market share, strategies, and key developments.
Analysis of growth challenges: The report includes a
comprehensive analysis of factors that may pose challenges to the
growth of companies in the blood culture tests market, providing a
well-rounded view of the market dynamics.
Buy this Research @
https://www.arizton.com/market-reports/blood-culture-tests-market
Post-Purchase Benefit
- 1hr of free analyst discussion
- 10% off on customization
Vendors
Key Company Profiles
- BD
- BIOMÉRIEUX
- Bruker
- Danaher
- Terumo Corporation
- Thermo Fisher Scientific
Other Prominent Vendors
- Abbott
- Autobio
- Axiom
- Biolab Scientific
- Cardinal Health
- DiaSorin S.p.A.
- F. Hoffmann-La Roche
- Hardy Diagnostics
- HiMedia Laboratories
- ITL BioMedical
- Kurin Inc
- Labotronics Scientific
- Meditech Technologies India Private Limited
- OpGen
- Render Biotech Co., Ltd.
- SARSTEDT AG & Co KG
- Siemens Healthineers AG
- Scenker Biological Technology Co., Ltd
- T2 Biosystems (T2Bio)
Market Segmentation
Sample Type
- Bacterial Sample
- Non-bacterial Sample
Method
- Manual/Conventional Blood Culture
- Automated Blood Culture
Product
- Consumables
- Test Equipment
End-users
- Hospital-based Laboratories
- Clinical Laboratories
- Academic & Research Laboratories/Centers
- Others
Geography
- North America
-
- Europe
-
- Germany
- France
- The UK
- Italy
- Spain
- Russia
- Poland
- APAC
-
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Latin America
-
- Middle East &
Africa
-
- Turkey
- Saudi Arabia
- South Africa
- The UAE
Key Questions Answered in the Report:
How big is the blood culture tests market?
Which region dominates the global blood culture tests market
share?
What are the significant trends in the blood culture tests
market?
What is the growth rate of the global blood culture tests
market?
Who are the key players in the global blood culture tests
market?
How big is the blood culture tests market?
Which region dominates the global blood culture tests market
share?
What is the growth rate of the global blood culture tests
market?
Who are the key players in the global blood culture tests
market?
What are the significant trends in the blood culture tests
market?
How big is the blood culture tests market?
What are the significant trends in the blood culture tests
market?
Which region dominates the global blood culture tests market
share?
Who are the key players in the global blood culture tests
market?
What is the growth rate of the global blood culture tests
market?
Get the Detailed TOC @
https://www.arizton.com/market-reports/blood-culture-tests-market
Check Out Some of the Top Selling Research
Reports:
Syringes And Needles Market - Global Outlook & Forecast
2024-2029
U.S. Clinical Laboratory Tests Market - Industry Outlook
& Forecast 2024-2029
HIV Rapid Test Kits Market - Global Outlook & Forecast
2023-2028
Blood Glucose Test Strips Market - Global Outlook and
Forecast 2021-2026
Why Arizton?
100% Customer Satisfaction
24x7 availability – we are always there when you need
us
200+ Fortune 500 Companies trust Arizton's
report
80% of our reports are exclusive and first in the
industry
100% more data and analysis
1500+ reports published till
date
About
Us:
Arizton Advisory and Intelligence is an innovative and
quality-driven firm that offers cutting-edge research solutions to
clients worldwide. We excel in providing comprehensive market
intelligence reports and advisory and consulting
services.
We offer comprehensive market research reports on consumer goods
& retail technology, automotive and mobility, smart tech,
healthcare, life sciences, industrial machinery, chemicals,
materials, I.T. and media, logistics, and packaging. These reports
contain detailed industry analysis, market size, share, growth
drivers, and trend
forecasts.
Arizton comprises a team of exuberant and well-experienced
analysts who have mastered generating incisive reports. Our
specialist analysts possess exemplary skills in market research. We
train our team in advanced research practices, techniques, and
ethics to outperform in fabricating impregnable research
reports.
Contact
Us
Call:
+1-312-235-2040
+1 302 469
0707
Mail: enquiry@arizton.com
Contact
Us: https://www.arizton.com/contact-us
Blog: https://www.arizton.com/blog
Website: https://www.arizton.com/
Photo:
https://mma.prnewswire.com/media/2412219/BLOOD_CULTURE_TESTS_MARKET.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/blood-culture-tests-market-anticipated-to-reach-new-heights---the-market-to-worth-8-98-billion-by-2029--exclusive-research-report-by-arizton-302144780.html
SOURCE Arizton Advisory & Intelligence